Zobrazeno 1 - 10
of 225
pro vyhledávání: '"K. Liippo"'
Autor:
Dai, Bowen1,2 (AUTHOR), Han, Shujuan1 (AUTHOR), Shen, Yuanfang1 (AUTHOR), Li, Zhi1 (AUTHOR), Chen, Shouhang1 (AUTHOR), Wang, Zhuangzhuang1 (AUTHOR), Yuan, Yan1 (AUTHOR), Zhang, Ruyu1 (AUTHOR), Wang, Chenyu1 (AUTHOR), Zheng, Jiaying1 (AUTHOR), Liang, Qiujing1 (AUTHOR), Wang, Qingmei1 (AUTHOR), Zhang, Yaodong3 (AUTHOR), Zhang, Xiaolong4 (AUTHOR), Wang, Fang1 (AUTHOR) 13783637576@139.com, Jin, Yuefei1,2 (AUTHOR) jyf201907@zzu.edu.cn
Publikováno v:
BMC Infectious Diseases. 9/13/2024, Vol. 24 Issue 1, p1-5. 5p.
Autor:
Anne Pietinalho, Lauri A. Laitinen, Anssi Sovijärvi, Vuokko L. Kinnula, S. Vilkman, Eva Kontula, O. Säynäjäkangas, K. Liippo
Publikováno v:
Respiratory Medicine. 101(7):1419-1425
SummaryThe Finnish National Prevention and Treatment Programme for Chronic Bronchitis and COPD, launched in 1998, has, to date, been running for 6 years (2003).The goals of this action programme were to reduce the incidence of COPD and the number of
Publikováno v:
Respiratory Medicine. 95:387-392
The aim of the study was to investigate which features predict favourable response to omeprazole therapy in asthmatics with gastro-oesophageal reflux (GER). The study population consisted of 52 outpatient asthmatics with GER who had completed an inte
Publikováno v:
Annals of Medicine. 32:279-283
We evaluated the usefulness of the ligase chain reaction (LCR) (Abbott LCx Mycobacterium tuberculosis assay) during the initial diagnosis of tuberculosis. LCx was carried out in parallel with conventional methods for the analysis of clinical samples.
Publikováno v:
Bone. 22:577-582
Clodronate is a novel drug used for inhibiting osteoclastic activity. The aim of the present double-blind study was to evaluate the efficacy and tolerability of clodronate (Leiras, Finland) in corticosteroid-induced bone loss among asthmatic patients
Autor:
A. Lindqvist, M. Silvasti, U. Suuronen, A. Knuuttila, V. Vilkka, A. Poukkula, Satu Lähelmä, K. Alanko, K. Kilpiö, J. Laitinen, E.-M. Ruotsalainen, K. Liippo, M. Paananen, E.-R. Salomaa, K. Lehtonen, P. Toivanen, S. Koskinen
Publikováno v:
Clinical Drug Investigation. 16:101-110
Objective: The clinical efficacy, tolerability and acceptability of a new multidose powder inhaler (MDPI) [Easyhaler®, Orion Pharma, Finland] containing a high dose (500 μg/dose) of beclomethasone dipropionate (BDP) were compared with those of BDP
Autor:
Rolf A. Stahel, Karin Mattson, N. v. Walree, K. Liippo, Joachim von Pawel, Peter Drings, P. Kellokumpu-Lehtinen, Christian Manegold, W. W. ten Bokkel-Huinink, C. Sederholm, S. Ricci, Gunnar Wagenius, B. Bergman, W. Dornoff, Assad Chemaissani
Publikováno v:
Annals of Oncology. 8:525-529
Summary Background This randomised study was designed to determine the response rate, survival and toxicity of single-agent gemcitabine and cisplatin-etoposide in chemo-naive patients with locally advanced or metastatic non-small-cell lung cancer. Pa
Publikováno v:
Cancer Chemotherapy and Pharmacology. 39:212-216
In this pharmacokinetics study, concentrations of toremifene (TOR), a new antiestrogen, were measured after a 7-day oral treatment in serum, lung, and tumor tissue to determine the optimal dose of TOR for the modulation of clinical multidrug resistan
Publikováno v:
Respiratory Medicine. 90(6):339-342
The use of inhaled corticosteroids in bronchial asthma has widened, but there is a lack of data on their effect on bone collagen synthesis and degradation. This paper reports the effect of three dose levels (200, 1000 and 2000 micrograms day-1, 3 wee
Publikováno v:
Journal of Infection. 28:131-139
Dirithromycin, a new once-daily macrolide, was studied in a multicentre, randomised, double-blind trial in community-acquired bacterial pneumonia. A total of 591 patients received either a single daily dose of dirithromycin, 500 mg, or erythromycin,